EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $121 | -65.3% | 6,200 | -49.7% | 0.00% | -100.0% |
Q1 2023 | $349 | +7.1% | 12,316 | +10.3% | 0.00% | 0.0% |
Q4 2022 | $326 | -99.9% | 11,165 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $295,000 | -39.8% | 11,165 | +1.2% | 0.00% | 0.0% |
Q2 2022 | $490,000 | -5.2% | 11,037 | +8.4% | 0.00% | 0.0% |
Q1 2022 | $517,000 | +6.8% | 10,180 | +7.2% | 0.00% | 0.0% |
Q4 2021 | $484,000 | -10.5% | 9,494 | -1.5% | 0.00% | 0.0% |
Q3 2021 | $541,000 | +31.3% | 9,641 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $412,000 | +2.5% | 9,641 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $402,000 | -25.3% | 9,641 | -16.5% | 0.00% | 0.0% |
Q4 2020 | $538,000 | +3.9% | 11,550 | -5.3% | 0.00% | 0.0% |
Q3 2020 | $518,000 | -14.8% | 12,200 | -3.6% | 0.00% | 0.0% |
Q2 2020 | $608,000 | -3.3% | 12,661 | -7.4% | 0.00% | -50.0% |
Q1 2020 | $629,000 | -16.6% | 13,675 | +8.0% | 0.00% | 0.0% |
Q4 2019 | $754,000 | -6.5% | 12,658 | -12.7% | 0.00% | 0.0% |
Q2 2019 | $806,000 | +5.1% | 14,493 | -4.7% | 0.00% | 0.0% |
Q1 2019 | $767,000 | +48.1% | 15,209 | +9.0% | 0.00% | +100.0% |
Q4 2018 | $518,000 | -46.4% | 13,948 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $967,000 | +20.0% | 13,948 | +31.0% | 0.00% | 0.0% |
Q2 2018 | $806,000 | +43.7% | 10,648 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $561,000 | -9.1% | 10,648 | -7.8% | 0.00% | 0.0% |
Q4 2017 | $617,000 | -9.0% | 11,546 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $678,000 | -25.5% | 11,546 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $910,000 | -2.4% | 11,546 | +2.7% | 0.00% | -33.3% |
Q1 2017 | $932,000 | +14.5% | 11,244 | +9.6% | 0.00% | +50.0% |
Q4 2016 | $814,000 | -46.1% | 10,263 | -52.5% | 0.00% | 0.0% |
Q3 2016 | $1,510,000 | +4094.4% | 21,586 | +2216.1% | 0.00% | – |
Q2 2016 | $36,000 | -5.3% | 932 | 0.0% | 0.00% | – |
Q1 2016 | $38,000 | -54.2% | 932 | 0.0% | 0.00% | – |
Q4 2015 | $83,000 | +20.3% | 932 | 0.0% | 0.00% | – |
Q3 2015 | $69,000 | – | 932 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |